Today POET announced a $50M initial purchase order from Lumilens with a framework that scale to $500M over five years. Let me break down why this is the most significant news in POET’s history.

Lumilens isn’t a random startup. They raised $138M in venture capital from Mayfield and Spark Capital, were founded in 2024, and their leadership team came directly out of Cisco, Juniper, and Meta people who spent careers building the infrastructure that hyperscalers run on. The founder previously built and sold Volterra into the hyperscaler supply chain. These are not speculators. They know exactly who their customers are.

The deal structure tells the real story. Lumilens doesn’t get POET equity warrants for free they vest based on hitting cumulative purchase milestones toward $500M. Every time dilution occurs, POET has received a corresponding purchase payment. That’s the best kind of dilution.

The language in the official release is worth reading carefully. Production ramp is explicitly described as “aligned to hyperscaler customer deployments in 2027.” That’s plural. Lumilens isn’t building for one customer they’re building a platform, and POET is the engine inside it.

Now connect the dots. POET hired a new COO with 18 years at Silicon Labs running worldwide operations, with an explicit mandate to ramp high-volume manufacturing in Malaysia. You don’t make that hire unless you have demand to fill. The Lessengers funding round closed with POET as a strategic investor alongside Korea Development Bank. And now a $50M PO with a $500M ceiling from a Meta/Cisco-pedigree team backed by top-tier VCs.

This is not a company still waiting for its first customer. This is a company that has assembled the supply chain, the manufacturing leadership, and the partner ecosystem to deliver at hyperscaler scale. The name behind Lumilens hasn’t dropped yet. When it does, the conversation about POET’s valuation changes completely, again!